Oxygen4Life Welcomes David Blackledge to Advisory Board

Photo of author

Oxygen4Life, Inc., a pioneering medical device and life sciences company dedicated to revolutionizing the industry and focusing on the VA/DOD, is pleased to announce the addition of David Blackledge to its esteemed Advisory Board.

David Blackledge brings a wealth of experience to the Oxygen4Life team, further strengthening the company’s vision of delivering innovative solutions in healthcare. As a seasoned professional, David has dedicated his career to guiding startup and emerging businesses, particularly in various technology markets. His practice spans from entity formation to raising capital and fostering company growth. David’s unique perspective, cultivated over three decades in sales and operations management of high technology startups, equips him to provide invaluable guidance to business owners, investors, and stakeholders.

In addition to his legal expertise, David is an active investor in multiple angel groups and serves as a full-time faculty member at Grand Canyon University’s College of Business, where he was honored with the 2020-21 Teacher of the Year and Provost Excellence Award. He’s also deeply engaged in the entrepreneurial community, mentoring and judging in various Arizona-based business competitions. His commitment to education and innovation aligns seamlessly with Oxygen4Life’s mission to make a positive impact on healthcare.

David’s impressive academic background includes a degree in Management from Penn State Smeal College of Business, an MBA from George Washington University, and a J.D. from Arizona State University’s Sandra Day O’Connor College of Law.

What makes David’s involvement with Oxygen4Life even more remarkable is his early investment in the company. Witnessing the company’s rapid progress and remarkable impact in a short time, David reached out to become a board of advisor member, recognizing Oxygen4Life’s potential to disrupt the healthcare industry.

“I’m thrilled to be part of the Oxygen4Life team as an advisor,” David Blackledge shared. “Having invested in early-stage businesses for many years, I seek out companies that are true industry disruptors, led by exceptional leadership. With their groundbreaking medical devices and innovative nutraceuticals, Oxygen4Life stands out as one of those exceptional companies. Their potential to make an immediate and meaningful impact on healthcare and testing is evident, and the founders and advisors bring a wealth of experience that positions them for success.”

Mike Maunu, President and CEO of Oxygen4Life, Inc., expressed his enthusiasm for this valuable addition to the team. “David’s expertise and dedication to fostering business growth align perfectly with our mission at Oxygen4Life. We’re excited to welcome him to our Advisory Board, and we look forward to his contributions in propelling our vision of revolutionizing healthcare.”

Source: http://newswire.net/newsroom/pr/00000000-https-www-oxygen4lifeinc-com.html